Ahll Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -24.39%
(FY 2023)
- Ebitda -24.39%
(FY 2023)
- Net Worth -41.30%
(FY 2023)
- Total Assets -27.80%
(FY 2023)
About Ahll Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sriram Iyer, Konda Reddy, and Chandra Chivukula serve as directors at the Company.
- CIN/LLPIN
U85200TG2018PLC125317
- Company No.
125317
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2018
- Date of AGM
26 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ahll Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sriram Iyer  | Director | 27-Feb-2024 | Current |
| Konda Reddy | Director | 31-Mar-2023 | Current |
| Chandra Chivukula | Director | 18-Dec-2018 | Current |
Financial Performance of Ahll Diagnostics.
Ahll Diagnostics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 24.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ahll Diagnostics?
In 2023, Ahll Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Everest Infra Ventures (India) Private LimitedActive 10 years 3 monthsKonda Reddy is a mutual person
Apollo Dialysis Private LimitedActive 10 years 9 monthsSriram Iyer and Chandra Chivukula are mutual person
Apollo Specialty Hospitals Private LimitedActive 15 years 6 monthsSriram Iyer and Chandra Chivukula are mutual person
Apollomedics International Lifesciences LimitedActive 13 years 11 monthsChandra Chivukula is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ahll Diagnostics?
Unlock and access historical data on people associated with Ahll Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ahll Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ahll Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
